
CymaBay Therapeutics, Inc.
USD32.48
+0.01 (+0.03%)
CEO
Sujal A. Shah
IPO Date
2014-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.49
Prev. Close
$32.47
Day Low
$32.48
Day High
$32.50
52W Low
$7.26
52W High
$32.50
Market Cap
$3.73B
Volume
8.35M
| 14 Feb 2024 |
| UBS |
| Buy |
| Neutral |
| downgrade |
| 14 Feb 2024 | LifeSci Capital | Outperform | Market Perform | downgrade |
| 13 Feb 2024 | B. Riley Securities | Buy | Neutral | downgrade |
| 13 Feb 2024 | Raymond James | Strong Buy | Market Perform | downgrade |
| 13 Feb 2024 | JonesTrading | Buy | Hold | downgrade |
| 13 Feb 2024 | Cantor Fitzgerald | Overweight | Neutral | downgrade |
| 13 Feb 2024 | BTIG | Buy | Neutral | downgrade |